Free tool
FAERS Monitor: Advil Pm
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021393 or its brand name (Advil Pm, Diphenhydramine Hydrochloride, Ibuprofen). Reports on generic versions are filed under their own applications.
Reports
4,783
Serious
777
16% of reports
Hospitalization
190
Death reported
42
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,234
- somnolence456
- product use in unapproved indication346
- drug effective for unapproved indication284
- insomnia256
- feeling abnormal230
- dizziness197
- fatigue195
- intentional product misuse145
- overdose131
- headache121
- nausea114
- malaise109
- incorrect dose administered104
- drug effect incomplete101
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 38 |
| 2007 | 123 |
| 2008 | 56 |
| 2009 | 27 |
| 2010 | 390 |
| 2011 | 239 |
| 2012 | 263 |
| 2013 | 309 |
| 2014 | 331 |
| 2015 | 423 |
| 2016 | 506 |
| 2017 | 355 |
| 2018 | 442 |
| 2019 | 177 |
| 2020 | 218 |
| 2021 | 577 |
| 2022 | 155 |
| 2023 | 60 |
| 2024 | 35 |
| 2025 | 31 |
| 2026 | 28 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,376 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug effective for unapproved indicationSignal | 284 | 43.0 | 38.4 | 11,524 |
| drug effect incompleteSignal | 101 | 12.3 | 10.1 | 1,032 |
| somnolenceSignal | 456 | 10.0 | 9.1 | 3,702 |
| intentional product misuseSignal | 145 | 7.3 | 6.2 | 783 |
| product use in unapproved indicationSignal | 346 | 6.1 | 5.6 | 1,501 |
| insomniaSignal | 256 | 4.2 | 3.8 | 636 |
| feeling abnormalSignal | 230 | 4.2 | 3.7 | 569 |
| drug ineffectiveSignal | 1,234 | 4.1 | 3.9 | 3,105 |
| overdoseSignal | 131 | 2.7 | 2.3 | 137 |
| incorrect dose administeredSignal | 104 | 2.0 | 1.7 | 52 |
| dizziness | 197 | 1.7 | 1.5 | 62 |
| fatigue | 195 | 1.1 | 1.0 | 2 |
| malaise | 109 | 1.1 | 0.9 | 1 |
| headache | 121 | 0.8 | 0.7 | 3 |
| nausea | 114 | 0.6 | 0.5 | 25 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.